Short bowel syndrome (SBS) with intestinal failure Program in Pharmaceutical Benefits Scheme (PBS) 012-19100123
Expand allThis document outlines details of PBS-subsidised teduglutide for patients with short bowel syndrome (SBS) with intestinal failure.
For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.
Short bowel syndrome (SBS) with intestinal failure quick reference
Restrictions | Authority level and section | PA assessment | Processing system | Prescriber type | Prescriber self-serve |
Initial PB275 form | Written Electronic S100: teduglutide | No | OPA | Must be treated by a:
| Yes - delayed assessment. No additional free text information to assess. Assess and approve/reject as per usual process. |
Continuing PB276 form | Written Electronic S100: teduglutide | No | OPA | Must be treated by a:
| Yes - delayed assessment. No additional free text information to assess. Assess and approve/reject as per usual process. |
Balance of supply | Telephone Electronic S100: teduglutide | No | OPA | Must be treated by a:
| Yes |